← Eichor
Study identifier: NCT06956781 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

Condition: PTSD · Trauma · Pediatric ALL  ·  Sponsor: University of Rochester

PhaseNA
Planned participants200
Who can joinAll sexes, 8 Years to 17 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD

This description comes directly from the study's public registry record.

Talk to the study team

Chad E Shenk, PhD  ·  (585) 275-8704  ·  chad.shenk@rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Mt. Hope Family CenterRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06956781